ROYALTY PHARMA PLC shareholders Q2 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
CORNERCAP INVESTMENT COUNSEL INC 26,274$807,6630.14%
Executive Wealth Management, LLC 42,272$1,299,4610.13%
Graypoint LLC 43,949$1,350,9920.13%
Aquatic Capital Management LLC 79,600$2,4470.13%
Qube Research & Technologies Ltd 1,179,343$36,253,0040.13%
DARK FOREST CAPITAL MANAGEMENT LP 46,349$1,424,7680.13%
Handelsbanken Fonder AB 791,336$24,3260.13%
ExodusPoint Capital Management, LP 485,198$14,9150.12%
Andra AP-fonden 152,700$4,693,9980.12%
XTX Topco Ltd 20,911$642,8040.12%
Donoghue Forlines LLC 11,712$360,0270.11%
Mitsubishi UFJ Trust & Banking Corp 1,527,232$46,947,1120.11%
MARSHALL WACE, LLP 1,806,621$55,535,5300.11%
HRT FINANCIAL LP 362,739$11,1500.10%
Graham Capital Management, L.P. 111,806$3,436,9160.10%
Engineers Gate Manager LP 78,320$2,407,5570.09%
TWO SIGMA INVESTMENTS, LP 1,131,696$34,788,3350.09%
FMR LLC 33,884,250$1,041,601,8490.09%
SECTORAL ASSET MANAGEMENT INC 15,362$472,2280.08%
TWO SIGMA ADVISERS, LP 947,600$29,129,2240.07%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q2 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.